These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29196917)

  • 21. Simultaneous determination of metoprolol and its metabolites, α-hydroxymetoprolol and O-desmethylmetoprolol, in human plasma by liquid chromatography with tandem mass spectrometry: Application to the pharmacokinetics of metoprolol associated with CYP2D6 genotypes.
    Bae SH; Lee JK; Cho DY; Bae SK
    J Sep Sci; 2014 Jun; 37(11):1256-64. PubMed ID: 24648255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a new GC-MS method for the detection of tramadol, O-desmethyltramadol, 6-acetylmorphine and morphine in blood, brain, liver and kidney of Wistar rats treated with the combination of heroin and tramadol.
    Mahdy T; El-Shihi TH; Emara MM; Chericoni S; Giusiani M; Giorgi M
    J Anal Toxicol; 2012 Oct; 36(8):548-59. PubMed ID: 22933659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
    Arafa MH; Atteia HH
    Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the pharmacokinetics of tramadol: on the difference between CYP2D6 extensive and poor metabolizers.
    Di Patti F; Fanelli D; Pedersen RS; Giuliani C; Torricelli F
    J Theor Biol; 2008 Oct; 254(3):568-74. PubMed ID: 18640130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma.
    Rouini MR; Ardakani YH; Soltani F; Aboul-Enein HY; Foroumadi A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):207-11. PubMed ID: 16280260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pupillometry in healthy volunteers as a biomarker of tramadol efficacy.
    Matouskova O; Slanar O; Chytil L; Perlik F
    J Clin Pharm Ther; 2011 Aug; 36(4):513-7. PubMed ID: 21729116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study.
    Pedersen RS; Damkier P; Brosen K
    Clin Pharmacol Ther; 2005 Jun; 77(6):458-67. PubMed ID: 15961977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural elucidation of tramadol, its derivatives, and metabolites using chemical derivatization and liquid chromatography-high-resolution tandem mass spectrometry.
    Shamai Yamin T; Shifrovitch A; Madmon M; Prihed H; Weissberg A
    Rapid Commun Mass Spectrom; 2024 Oct; 38(20):e9881. PubMed ID: 39157950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of primary metabolites of tramadol in rat urine by LC-MS(n].
    Lu H; Wu D; Yan J; Zeng Q; Wu YP; Sun L
    Yao Xue Xue Bao; 2011 Aug; 46(8):968-75. PubMed ID: 22007524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
    Suzuki K; Naito T; Tanaka H; Yamada Y; Itoh K; Kawakami J
    Ther Drug Monit; 2020 Jun; 42(3):503-511. PubMed ID: 31613803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
    Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
    J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques.
    De Leo M; Giorgi M; Saccomanni G; Manera C; Braca A
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):228-36. PubMed ID: 19072864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of tramadol pharmacokinetics in correlation with CYP2D6 and clinical symptoms.
    Ahmadimanesh M; Naeini MB; Rouini MR; Shadnia S; Ghazi-Khansari M
    Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32681776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolite to parent drug concentration ratios in hair for the differentiation of tramadol intake from external contamination and passive exposure.
    Madry MM; Rust KY; Guglielmello R; Baumgartner MR; Kraemer T
    Forensic Sci Int; 2012 Nov; 223(1-3):330-4. PubMed ID: 23127661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the route dependency of the pharmacokinetics and neuro-pharmacokinetics of tramadol and its main metabolites in rats.
    Sheikholeslami B; Gholami M; Lavasani H; Rouini M
    Eur J Pharm Sci; 2016 Sep; 92():55-63. PubMed ID: 27365222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats.
    Jamali B; Sheikholeslami B; Hosseinzadeh Ardakani Y; Lavasani H; Rouini MR
    Drug Metab Pers Ther; 2017 Sep; 32(3):137-145. PubMed ID: 28917081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First report on the pharmacokinetics of tramadol and O-desmethyltramadol in exhaled breath compared to plasma and oral fluid after a single oral dose.
    Meyer MR; Rosenborg S; Stenberg M; Beck O
    Biochem Pharmacol; 2015 Dec; 98(3):502-10. PubMed ID: 26388171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients.
    Nasare NV; Banerjee BD; Suryakantrao Deshmukh P; Mediratta PK; Saxena AK; Ahmed RS; Bhattacharya SN
    Am J Ther; 2016; 23(3):e697-707. PubMed ID: 23567787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.
    Tzvetkov MV; Saadatmand AR; Lötsch J; Tegeder I; Stingl JC; Brockmöller J
    Clin Pharmacol Ther; 2011 Jul; 90(1):143-50. PubMed ID: 21562485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Pharm Biomed Anal; 2009 Feb; 49(2):354-66. PubMed ID: 19062215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.